Factory 99% Aripiprazole Powder CAS 129722-12-9 Chemical Intermediate Aripiprazole

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A520
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Aripiprazole
• CAS: 129722-12-9
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Treatment of Schizophrenia
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Aripiprazole
Appearance	White Powder
CAS NO.	129722-12-9
Molecular Formula	C23H27ClN4O2
Storage	Keep in a cool, dry, dark location

 

Aripiprazole is a psychotropic drug that belongs to the class of selective monoamine modulators. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors.

 

1. Treatment of Schizophrenia: Aripiprazole is prescribed for the management of schizophrenia in adults and adolescents, aiming to reduce symptoms such as hallucinations, delusions, and disorganized thinking.
2. Bipolar Disorder: It is also used for the treatment of manic or mixed episodes associated with bipolar I disorder, helping to stabilize mood and reduce irritability, aggression, and excessive energy.
3. Adjunctive Therapy in Major Depressive Disorder: In some cases, aripiprazole may be used as an adjunctive treatment to antidepressants in adults with major depressive disorder who have not responded adequately to monotherapy.

1. Dopamine Regulation: By acting as a partial agonist at D2 receptors, aripiprazole helps to regulate dopamine activity in the brain, which can alleviate psychotic symptoms and improve cognitive function.
2. Serotonin Modulation: Its action at serotonin receptors, particularly as an antagonist at 5-HT2A and an agonist at 5-HT1A, contributes to mood stabilization and reduction in anxiety-related symptoms.
3. Neuroprotective Effects: Some evidence suggests that aripiprazole may have neuroprotective properties, potentially slowing the progression of neurodegenerative processes in certain conditions.